Francois P Duhoux

28PUBLICATIONS
157CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 10, 2026
EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

|May 27, 2026
Can DNA Methylation in Peritumoral and Contralateral Breast Tissue Predict Recurrence or Second Breast Cancers?

|Feb 04, 2026
Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma.

Matteo Serra, Mattia Rediti, Laetitia Collet

|Nov 26, 2025
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

Andreas Papagiannis, Samira Majjaj, Francois P Duhoux

|Sep 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Séverine Guiu, Judith Balmaña, Pablo Lemercier

|Apr 17, 2025
Jacaric Acid Empowers RSL3-Induced Ferroptotic Cell Death in Two- and Three-Dimensional Breast Cancer Cell Models.

Géraldine Cuvelier, Perrine Vermonden, Pauline Debisschop

Pageof 5

Frequent Collaborators

6 joint publications

Christos Sotiriou

5 joint publications

Françoise Derouane

5 joint publications

Kevin Punie

5 joint publications

Michail Ignatiadis